Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
89,436,431
-
Share change
-
-322,366
-
Total reported value
-
$8,572,935,331
-
Put/Call ratio
-
242%
-
Price per share
-
$95.85
-
Number of holders
-
394
-
Value change
-
-$29,252,870
-
Number of buys
-
186
-
Number of sells
-
219
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q4 2020
As of 31 Dec 2020,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
394 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,436,431 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, Bellevue Group AG, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
394
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.